2008•Strait Pharmaceutical JournalRequires access

Cost-effectiveness analysis of three therapies for children's bronchopneumonia

Zhu Lin-qiao

Abstract

OBJECTIVE To compare the pharmacoeconomics outcome of three schemes in treating Bronchopneumonia in children.METHODS A retrospective study was conducted on the cost-effectiveness of cephathiamidin(group A),cefuroxime sodium(groupB)and ceftriaxone sodium(group C)in treatment of children's bronchopneumonia.RESULTS The costs for groupA,B and C were 2346.40 yuan,2659.70 yuan and 3020.50 yuan,respectively;the effective rates stood at 95.74%,92.16% and 91.67%,respectively(P0.05),and the cost-effectiveness ratio were 2450.80,2885.96 and 3294.97,respectively.CONCLUSION Scheme A was superior among the three.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Bronchopneumonia, Pharmacoeconomics, Medicine, Cefuroxime, Internal medicine, Pediatrics, Intensive care medicine, Antibiotics